CROSSROADS BETWEEN BIOLOGICAL AND CLINICAL ISSUES
TOWARDS INTEGRATED MANAGEMENT OF RHEUMATOID ARTHRITIS
Informazioni
Codice ECM: 75-330324-1
Crediti ECM: 4.5
Max Partecipanti: 750
Professione: Medico chirurgo
Disciplina: Allergologia e immunologia clinica, Medicina interna, Reumatologia
Obiettivo formativo n. 3: Documentazione clinica. Percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza - profili di cura
Responsabile Scientifico: Dott.ssa Elisa Gremese, Prof. Stefano Alivernini
Relatore: : silvagni ettore, venerito vincenzo, dott. fabio cacciapaglia, prof. stefano alivernini, prof.ssa elisa gremese, dott.ssa francesca romana spinelli, dott. francesco ciccia, dott. maurizio benucci, dott. simone parisi
Durata prevista dell’attività formativa: 3 ore (tempo medio stimato per acquisire le conoscenze e le competenze da parte di un utilizzatore medio)
Prezzo: Gratuito
Despite active research in the development of novel treatments for Rheumatoid Arthritis (RA) low-disease activity or clinical remission is achieved in 40-50% of patients. Moreover, approximately 50% of those who respond to therapy will relapse on drug tapering or withdrawal. Therefore, the variable rate of treatment response in RA and the fragility of remission may be due to the lack of complete knowledge of the molecular mechanisms promoting inflammation and its resolution contributing to the individual heterogeneity of the disease which is at clinical as well at biological level.
Based on these issues, the aims of this project will be to dissect the clinical and biological heterogeneity of RA, discussing and integrating the data obtained from high-definition dissection of inflammation at joint, extra-joint and systemic levels together with clinical parameters. This approach will provide new insights for the development of a novel integrated management towards precision medicine in RA.
Con il contributo non condizionante di:
Altri corsi che potrebbero interessarti
L’impatto sulla pelle delle terapie oncologiche:
uno sguardo al patient journey
WIN TOGETHER
The therapeutic alliance for IBD management
Follow Counselling e monitoraggio per il controllo dell’ipercolesterolemia.
